文献速递糖尿病肥胖与代谢综合征

肥胖青少年非酒精性脂肪性肝病与估计胰岛素抵抗:一项孟德尔随机化分析

Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

在904名肥胖儿童/青少年中以NAFLD相关遗传风险评分(GRS)为工具变量行孟德尔随机化,并在46 186名成人MAGIC数据集中分析PNPLA3 rs738409与HOMA-IR的关联及双向孟德尔随机化。结果显示GRS不预测ln-HOMA-IR(β=0.007,P=0.75),PNPLA3 rs738409与ln-HOMA-IR无关,反向孟德尔随机化亦未显示ln-HOMA-IR与NAFLD的因果关联。结论认为遗传影响的NAFLD不增加HOMA-IR,遗传影响的HOMA-IR不增加NAFLD风险。

要点

  • 肥胖青少年中NAFLD相关GRS每增加一个单位,NAFLD患病率增加20%(β=0.20,P<0.001)。
  • 该队列中GRS不预测ln-HOMA-IR(β=0.007,P=0.75)。
  • MAGIC成人数据集中PNPLA3 rs738409与ln-HOMA-IR无关联,双向孟德尔随机化未显示因果关联。

核心结论

  • 遗传影响的NAFLD不增加HOMA-IR,遗传影响的HOMA-IR不增加NAFLD风险。
  • 共享致病通路或孟德尔随机化设计未捕获的NAFLD亚型可能解释NAFLD与HOMA-IR之间的关联。

研究设计与样本

  • 在904名肥胖儿童/青少年中,以NAFLD相关遗传风险评分(GRS)为工具变量行孟德尔随机化。
  • NAFLD通过超声评估,胰岛素抵抗通过稳态模型评估(HOMA-IR)评估。
  • 在MAGIC Consortium 46 186名成人数据集中分析PNPLA3 rs738409与HOMA-IR的关联。
  • 使用两个大型数据集行两样本孟德尔随机化以检验反向因果(HOMA-IR增加NAFLD风险)。

主要发现

  • GRS每增加一个单位,NAFLD患病率增加20%(β系数=0.20,P<0.001)。
  • NAFLD与ln-HOMA-IR相关(β系数=0.28,P<0.001)。
  • 若NAFLD-HOMA-IR完全因果关联,GRS每增加一个单位ln-HOMA-IR的预期增加为0.056(0.28*0.20);若75%因果关联,则为0.042。
  • 本队列中GRS不预测ln-HOMA-IR(β系数=0.007,P=0.75)。
  • MAGIC队列中PNPLA3 rs738409与ln-HOMA-IR无关联;两样本孟德尔随机化未显示ln-HOMA-IR与NAFLD的因果关联。

局限性

  • 共享致病通路或孟德尔随机化设计未捕获的NAFLD亚型可能解释NAFLD与HOMA-IR之间的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Nonalcoholic fatty liver disease (NAFLD) is associated with insulin resistance (IR) and predicts type 2 diabetes. Currently, it is uncertain whether NAFLD may directly cause IR or vice versa. OBJECTIVE: To test the hypothesis that NAFLD is causally related to IR. DESIGN AND METHODS: We performed a Mendelian randomization (MR) in 904 obese children/adolescents using an NAFLD-related genetic risk score (GRS) as an instrumental variable. We assessed NAFLD by ultrasonography and IR by homeostasis model assessment (HOMA-IR). We also interrogated the MAGIC Consortium dataset of 46 186 adults to assess the association between PNPLA3 rs738409 (ie, the most robust NAFLD-related polymorphism) and HOMA-IR, and we performed a 2-sample MR with 2 large datasets to test reverse causation (HOMA-IR increasing the risk of NAFLD). RESULTS: Nonalcoholic fatty liver disease prevalence increased by 20% for every increase in the GRS (β-coefficient = 0.20, P < 0.001), and NAFLD was associated with ln-HOMA-IR (β-coefficient = 0.28, P < 0.001). Thus, the expected increase in ln-HOMA-IR for every increase in the GRS (expected β-coefficient) was 0.056 (0.28*0.20) in the case of complete NAFLD-HOMA-IR causal association, and 0.042 in the case of 75% causality. In our cohort, the GRS did not predict ln-HOMA-IR (β-coefficient = 0.007, P = 0.75). In the MAGIC cohort, the PNPLA3 rs738409 did not associate with ln-HOMA-IR. The 2-sample MR failed to show a causal association between ln-HOMA-IR and NAFLD. CONCLUSIONS: Our study shows that genetically-influenced NAFLD does not increase HOMA-IR, and genetically-influenced HOMA-IR does not increase the risk of NAFLD. Shared pathogenic pathways or NAFLD subtypes not "captured" by our MR design might underpin the association between NAFLD and HOMA-IR.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Morandi A, Di Sessa A, Zusi C, et al. Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis. J Clin Endocrinol Metab. 2020. PMID: 32841326. doi:10.1210/clinem/dgaa583

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。